Development and preliminary validation of questionnaire for infection process and prevention of 2019 novel coronavirus infection in medical staffs_Chinese Journal of Evidence-Based Medicine

Authors：

WANG Yunyun ¹ , JIN Yinghui ^1,2,3,4 , DENG Tong ^1,2 , TAN Liming ^3,4 , CHEN Zhimin ⁵ , MA Linlu ¹ , ZHAO Mingjuan ^1,2 , ZI Hao ^1,2 , WANG Yongbo ¹ , WANG Ying ⁶ , HUANG Qiao ¹ , HUANG Di ^1,7 , LUO Lisha ¹ , FANG Cheng ¹ , GUO Yi ¹ , LI Binghui ^1,2 , LI Xuhui ¹ , CAO Yue ¹ , WENG Hong ¹ , PAN Zhenyu ⁸ , PEI Bin ⁹ , YANG Jian ^10,11 ,  REN Xuequn ² ,  ZENG Xiantao ^1,12,13,14 ,  WANG Xinghuan ^1,7,12,15

1. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R.China;
2. Institute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng 475000, P.R.China;
3. Second People's Hospital of Huaihua City, Huaihua 418000, P.R.China;
4. Center for Evidence-Based Medicine and Clinical Research, Key Laboratory of Huaihua City, Huaihua 418000, P.R.China;
5. Division of Social and Medical Development, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R.China;
6. Office of Nosocomial Infection Control, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R.China;
7. Leishenshan Hospital in Wuhan, Wuhan 430200, P.R.China;
8. Division of Medical Affairs, Zhongnan Hospital of Wuhan University, Wuhan 430071, China;
9. Center for Evidence-Based Medicine, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang 441000, P.R.China;
10. Institute of Evidence-Based and Translational Medicine, China Three Gorges University, Yichang 443002, P.R.China;
11. Yichang NO.1 Hospital, Renmin Hospital of China Three Gorges University, Yichang 443000, P.R.China;
12. Center for Evidence-Based and Translational Medicine, Wuhan University, Wuhan 430071, P.R.China;
13. Global Health Institute, Wuhan University, Wuhan 430072, P.R.China;
14. Division of Personnel Services, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R.China;
15. Institute of Hospital Management, Wuhan University, Wuhan 430071, P.R.China;

Corresponding author：

REN Xuequn, Email: renxuequn001@163.com; ZENG Xiantao, Email: zengxiantao1128@163.com; WANG Xinghuan, Email: wangxinghuan1965@163.com

Keywords：

SARS-CoV-2; COVID-19; Medical staff infection; Prevention and control of hospital infection; Questionnaire development

DOI：

10.7507/1672-2531.202002158

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To develop the questionnaire and test its reliability for investigating route, prevention, and control of SARS-CoV-2 infection in medical staffs.Methods This questionnaire was development based on the COVID-19 relevant guidelines, official documents issued by the National Health Committee of the People's Republic of China, and published studies. The development group performed repeated discussions and drafted the first questionnaire, then performed expert consultation and revised the draft according to their suggestions. Eventually, some frontline medical staffs were invited to carry out pre-test investigation of the questionnaire and test its reliability.Results The first draft included 48 items; 18 experts were invited in the first round questionnaire and 10 experts in the second round questionnaire. The positive coefficient of experts in these two rounds was both greater than 75%, and the authority coefficient of experts' opinions was greater than 0.70. The variation coefficient of these items was between 0.00 and 0.35, the coordination coefficient of experts was 0.193 (P<0.05). The experts of above two rounds put forward 14 suggestions for text modification or adjustment options of some items; after the development group held repeatedly discussions, a total of 8 items were performed secondary consultation and finally reached consensus. The final questionnaire included two domains of questionnaire before and after confirmed diagnosis. The domain "before confirmed diagnosis" covered 4 sections and 29 items involving infectious cause, plan and knowledge of prevention and control, and psychological symptoms. The domain "after confirmed diagnosis" covered 5 sections and 21 items, included symptoms, treatment, and psychological status after diagnosis; impact on the surrounding environment and people, and awareness of protection after infection. The pre-test results showed that the total items were considerably numerous, some items were difficult to understand, some laboratory results and treatment conditions were ambiguous, etc. After modification and re-testing, the test-re-test reliability of each domain was between 0.74 and 0.93, and the overall re-test reliability of the questionnaire content was 0.82.Conclusions This research has developed a questionnaire for investigating infection process, prevention and control of SARS-CoV-2 infection in medical staff, and the items considered two domains prior to and after confirmed diagnosis. The reliability and practicability of the questionnaire are acceptable.

Citation： WANG Yunyun, JIN Yinghui, DENG Tong, TAN Liming, CHEN Zhimin, MA Linlu, ZHAO Mingjuan, ZI Hao, WANG Yongbo, WANG Ying, HUANG Qiao, HUANG Di, LUO Lisha, FANG Cheng, GUO Yi, LI Binghui, LI Xuhui, CAO Yue, WENG Hong, PAN Zhenyu, PEI Bin, YANG Jian, REN Xuequn, ZENG Xiantao, WANG Xinghuan. Development and preliminary validation of questionnaire for infection process and prevention of 2019 novel coronavirus infection in medical staffs. Chinese Journal of Evidence-Based Medicine, 2020, 20(6): 723-736. doi: 10.7507/1672-2531.202002158 Copy

1.	王辰, 王行环. 实用新型冠状病毒肺炎诊疗手册. 北京: 人民卫生出版社, 2020.
2.	国家卫生健康委员会. 国家卫生健康委关于修订新型冠状病毒肺炎英文命名事宜的通知. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/33393aa53d984ccdb1053a52b6bef810.shtml.
3.	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223): 497-506.
4.	中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析. 中华流行病学杂志, 2020, 41(2): 145-151.
5.	Dickson JP. Improving survey questions: design and evaluation. J Mark Res, 1997, 34(2): 296-298.
6.	靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(完整版). 医学新知, 2020, 30(1): 35-64.
7.	Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res, 2020, 7(1): 4.
8.	World Health Organization. Coronavirus disease (COVID-19) technical guidance: Early investigations protocols. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations.
9.	国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
10.	国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发新型冠状病毒肺炎防控方案(第四版)的通知. Available from: http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4.shtml.
11.	国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知. Available from: http://bgs.satcm.gov.cn/zhengcewenjian/2020-02-06/12847.html.
12.	国家卫生健康委办公厅. 关于印发医疗机构内新型冠状病毒感染预防与控制技术指南(第一版)的通知. Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202001/b91fdab7c304431eb082d67847d27e14.shtml.
13.	World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125.
14.	中华人民共和国卫生部. 医院隔离技术规范. Available from: http://www.nhc.gov.cn/cmsresources/mohyzs/cmsrsdocument/doc5841.pdf.
15.	中华人民共和国卫生部. 医务人员手卫生规范. 中华医院感染学杂志, 2009, 19(12): Ⅰ-Ⅱ.
16.	国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发新型冠状病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)的通知. Available from: http://www.nhc.gov.cn/yzygj/s7659/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
17.	国家卫生健康委办公厅. 国家卫生健康委办公厅关于进一步加强疫情防控期间医务人员防护工作的通知. Available from: http://www.nhc.gov.cn/yzygj/s7659/202002/75c6e88ecbeb42a9a26acb538383e2fc.shtml.
18.	国家卫生健康委员会. 医院感染管理办法(卫生部令第48号). Available from: http://www.nhc.gov.cn/zwgk/wlwl/200804/5a92cc5c37234062834ed79bb0329c3b.shtml.
19.	国家卫生健康委疾控局. 新型冠状病毒感染的肺炎疫情紧急心理危机干预指导原则. Available from: http://zw.china.com.cn/2020-01/27/content_75652045.html?f=pad&a=true.
20.	国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第五版修正版)的通知. Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/09/content_5476407.htm.
21.	靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版). 解放军医学杂志, 2020, 45(1): 1-20.
22.	Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
23.	陈恳, 梁舒瑶, 闫盈盈, 等. 用德尔菲法确定伏立康唑个体化用药指南临床问题与结局指标. 中国临床药理学杂志, 2016, 32(4): 368-369+381.
24.	陈晓君. 基于循证构建住院患者跌倒管理模型的研究. 杭州: 浙江大学, 2014.
25.	李舍予, 黄文治, 廖雪莲, 等. 新型冠状病毒感染医院内防控的华西紧急推荐. 中国循证医学杂志, 2020, 20(2): 125-133.

1. 王辰, 王行环. 实用新型冠状病毒肺炎诊疗手册. 北京: 人民卫生出版社, 2020.
2. 国家卫生健康委员会. 国家卫生健康委关于修订新型冠状病毒肺炎英文命名事宜的通知. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/33393aa53d984ccdb1053a52b6bef810.shtml.
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223): 497-506.
4. 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析. 中华流行病学杂志, 2020, 41(2): 145-151.
5. Dickson JP. Improving survey questions: design and evaluation. J Mark Res, 1997, 34(2): 296-298.
6. 靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(完整版). 医学新知, 2020, 30(1): 35-64.
7. Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res, 2020, 7(1): 4.
8. World Health Organization. Coronavirus disease (COVID-19) technical guidance: Early investigations protocols. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations.
9. 国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
10. 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发新型冠状病毒肺炎防控方案(第四版)的通知. Available from: http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4.shtml.
11. 国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知. Available from: http://bgs.satcm.gov.cn/zhengcewenjian/2020-02-06/12847.html.
12. 国家卫生健康委办公厅. 关于印发医疗机构内新型冠状病毒感染预防与控制技术指南(第一版)的通知. Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202001/b91fdab7c304431eb082d67847d27e14.shtml.
13. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125.
14. 中华人民共和国卫生部. 医院隔离技术规范. Available from: http://www.nhc.gov.cn/cmsresources/mohyzs/cmsrsdocument/doc5841.pdf.
15. 中华人民共和国卫生部. 医务人员手卫生规范. 中华医院感染学杂志, 2009, 19(12): Ⅰ-Ⅱ.
16. 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发新型冠状病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)的通知. Available from: http://www.nhc.gov.cn/yzygj/s7659/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
17. 国家卫生健康委办公厅. 国家卫生健康委办公厅关于进一步加强疫情防控期间医务人员防护工作的通知. Available from: http://www.nhc.gov.cn/yzygj/s7659/202002/75c6e88ecbeb42a9a26acb538383e2fc.shtml.
18. 国家卫生健康委员会. 医院感染管理办法(卫生部令第48号). Available from: http://www.nhc.gov.cn/zwgk/wlwl/200804/5a92cc5c37234062834ed79bb0329c3b.shtml.
19. 国家卫生健康委疾控局. 新型冠状病毒感染的肺炎疫情紧急心理危机干预指导原则. Available from: http://zw.china.com.cn/2020-01/27/content_75652045.html?f=pad&a=true.
20. 国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第五版修正版)的通知. Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/09/content_5476407.htm.
21. 靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版). 解放军医学杂志, 2020, 45(1): 1-20.
22. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
23. 陈恳, 梁舒瑶, 闫盈盈, 等. 用德尔菲法确定伏立康唑个体化用药指南临床问题与结局指标. 中国临床药理学杂志, 2016, 32(4): 368-369+381.
24. 陈晓君. 基于循证构建住院患者跌倒管理模型的研究. 杭州: 浙江大学, 2014.
25. 李舍予, 黄文治, 廖雪莲, 等. 新型冠状病毒感染医院内防控的华西紧急推荐. 中国循证医学杂志, 2020, 20(2): 125-133.

Chinese Journal of Evidence-Based Medicine

Development and preliminary validation of questionnaire for infection process and prevention of 2019 novel coronavirus infection in medical staffs

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content